undamentalytics Newsletter
Sign in

Eton Pharmaceuticals, Inc. balance sheet

At the end of fiscal 2025, Eton Pharmaceuticals, Inc. had total assets of $92.1m, total liabilities of $66.0m and shareholders' equity of $26.2m. It held $25.9m in cash against $30.6m of debt: net debt of $4.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1221141621152627
Receivables0052351225
Inventory01111151510
Total current assets1525242027416169
Total assets17262725327692116
Accounts payable1222241114
Total current liabilities245616203845
Short-term debt——115099
Long-term debt57550302219
Total debt57775303128
Total liabilities711101216526669
Shareholders' equity1118181315242647
Non-controlling interests and other (assets − liabilities − equity)—−2——————
Net debt (negative = net cash)−7−14−7−10−161551
Shares outstanding18m24m25m25m26m27m27m28m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ETON vs NAGEETON vs ZVRAETON vs NAII

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Eton Pharmaceuticals, Inc.